EMA
safety_alert
· 2026-03-13
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 March 2026
Summary
PRAC warned of a known risk of aseptic meningitis with the chikungunya vaccine Ixchiq, prompting safety communications.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
PRAC warns about known risk of aseptic meningitis with chikungunya vaccine Ixchiq